Cytotoxic rhamnolipid micelles drive acute virulence in Pseudomonas aeruginosa
- 12 March 2024
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 92 (3) , e0040723
Abstract
Pseudomonas aeruginosa is an opportunistic human pathogen that has developed multi- or even pan-drug resistance toward most frontline and last resort antibiotics, leading to increasing frequency of infections and deaths among hospitalized patients, especially those with compromised immune systems. Further complicating treatment, P. aeruginosa produces numerous virulence factors that contribute to host tissue damage and immune evasion, promoting bacterial colonization and pathogenesis. In this study, we demonstrate the importance of rhamnolipid production in host-pathogen interactions. Secreted rhamnolipids form micelles that exhibited highly acute toxicity toward murine macrophages, rupturing the plasma membrane and causing organellar membrane damage within minutes of exposure. While rhamnolipid micelles (RMs) were particularly toxic to macrophages, they also caused membrane damage in human lung epithelial cells, red blood cells, Gram-positive bacteria, and even noncellular models like giant plasma membrane vesicles. Most importantly, rhamnolipid production strongly correlated with P. aeruginosa virulence against murine macrophages in various panels of clinical isolates. Altogether, our findings suggest that rhamnolipid micelles are highly cytotoxic virulence factors that drive acute cellular damage and immune evasion during P. aeruginosa infections.Keywords
Funding Information
- HHS | NIH | National Institute of General Medical Sciences (R35GM129294)
- Cystic Fibrosis Foundation (KIRIEN20I0, XU23H0, KANG19H0, KANG22H0)
- American Heart Association (903591)
This publication has 88 references indexed in Scilit:
- Pseudomonas aeruginosa rhamnolipid micelles deliver toxic metabolites and antibiotics into Staphylococcus aureusiScience, 2021
- Giant Plasma Membrane Vesicles: An Experimental Tool for Probing the Effects of Drugs and Other Conditions on Membrane Domain Stability2018
- Current status in biotechnological production and applications of glycolipid biosurfactantsApplied Microbiology and Biotechnology, 2016
- Antimicrobial activity of rhamnolipids against Listeria monocytogenes and their synergistic interaction with nisinFood Control, 2013
- Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunityInternational Journal of Medical Microbiology, 2007
- Physicochemical characterization and antimicrobial properties of rhamnolipids produced by Pseudomonas aeruginosa 47T2 NCBIM 40044Biotechnology and Bioengineering, 2002
- Pseudomonas aeruginosa outer membrane protein F is an adhesin in bacterial binding to lung epithelial cells in cultureMicrobial Pathogenesis, 2002
- Virulence Factors from Pseudomonas aeruginosa Increase Lung Epithelial PermeabilityLung, 2000
- Inhibition of Macrophage Phagocytosis by Pseudomonas aeruginosa Rhamnolipids In Vitro and In VivoCurrent Microbiology, 1996
- Effects of Pseudomonas aeruginosa rhamnolipids on human monocyte-derived macrophagesJournal of Leukocyte Biology, 1992